Clinical Trials Directory

Trials / Sponsors / Apnimed

Apnimed

Industry · 14 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingSafety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
Sleep Apnea
Phase 22025-04-02
Enrolling By InvitationContinuation Protocol for Obstructive Sleep Apnea (OSA)
OSA
Phase 32024-07-03
CompletedStudy That Tests AD109 in Patients Taking GLP-1 Drugs
OSA
Phase 22024-05-20
CompletedParallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study)
OSA
Phase 32023-09-16
CompletedParallel Arm Trial of AD109 and Placebo With Patients With OSA (LunAIRo)
OSA
Phase 32023-08-28
CompletedAD816 Crossover Study
OSA, Obstructive Sleep Apnea
Phase 22023-04-28
CompletedParallel Arm Trial of AD109 and AD504 In Patients With OSA
OSA - Obstructive Sleep Apnea
Phase 22021-11-29
CompletedStudy for Efficacy and Dose Escalation of AD313 + Atomoxetine (SEED)
Obstructive Sleep Apnea
Phase 1 / Phase 22021-10-19
CompletedTrial of AD113 and Atomoxetine in OSA Patients With Hypertension
Obstructive Sleep Apnea, Hypertension
Phase 22021-07-31
CompletedAD109 Dose Finding in Mild to Moderate OSA
Obstructive Sleep Apnea
Phase 22020-12-22
CompletedCrossover Trial of AD182 and AD504 in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Phase 22020-12-01
CompletedCrossover Trial of AD109 in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Phase 22020-10-27
CompletedCrossover Trial of AD036 in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Phase 22020-07-15
CompletedTrial of AD036 in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Phase 22019-03-07